Workflow
7.1犀牛财经晚报:多家房企债务重组提速 首家地方AMC冲刺IPO
Xi Niu Cai Jing·2025-07-01 10:29

Group 1 - The first batch of 26 new floating rate funds has been launched, with over half already announced [1] - He Yuan Biological's IPO application has passed the review, marking the first successful IPO under the fifth set of standards for the Sci-Tech Innovation Board [1] - Multiple real estate companies are accelerating debt restructuring, with over 75% of holders supporting the offshore debt restructuring agreement from Country Garden [1] Group 2 - In June, China's heavy truck wholesale sales reached approximately 92,000 units, a year-on-year increase of about 29% [2] - The market for charging treasures in Huaqiangbei still includes products without 3C certification, despite increased scrutiny [2] - Guangzhou has launched its first "immediate refund" point for departure tax refunds, with a significant increase in tax refund applications and sales [3] Group 3 - Standard Chartered Bank faces a lawsuit related to the 1MDB scandal, with claims of failing to perform anti-money laundering checks on over $2.7 billion [3] - Perfect World has initiated an anti-corruption campaign, dismissing multiple individuals involved in bribery and misconduct [4] - Douyin e-commerce has clarified that there are no channels for obtaining sales permissions without followers, emphasizing adherence to established rules [4] Group 4 - Hebei Asset Management has submitted an IPO application, potentially becoming the first local asset management company to list on the Hong Kong Stock Exchange [4] - Tailong Pharmaceutical plans to register and issue up to 800 million yuan in short-term financing bonds [5] - Chang Aluminum's subsidiary has signed a contract worth 165 million yuan for a cleanroom construction project [6] Group 5 - Guomai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025 [7] - Kidswant anticipates a net profit growth of 50% to 100% for the first half of 2025 [8] - The Shanghai Composite Index rose by 0.39%, with innovation drug stocks experiencing significant gains [9][10]